XML 36 R25.htm IDEA: XBRL DOCUMENT
v3.25.1

Credit facility (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2025
Credit Facility |
SCHEDULE OF FAIR VALUE ASSETS ON RECURRING BASIS | The Company’s financial assets that are measured at fair value on a recurring basis by level within the fair value hierarchy are as follows: SCHEDULE OF FAIR VALUE ASSETS ON RECURRING BASIS
|  | Level 1 |  |  | Level 2 |  |  | Level 3 |  |  | Total |
|  | As of March 31, 2025 |
|  | Level 1 |  |  | Level 2 |  |  | Level 3 |  |  | Total |
|  | US$ |
Assets: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Investment in Plantify |  |  | 782 |  |  |  | - |  |  |  | - |  |  |  | 782 |
Investment in Solterra |  |  | 230 |  |  |  | - |  |  |  | - |  |  |  | 230 |
Solar photovoltaic joint venture project |  |  | - |  |  |  | - |  |  |  | 1,252 |  |  |  | 1,252 |
Loan granted to MitoCareX |  |  | - |  |  |  | - |  |  |  | 477 |  |  |  | 477 |
Convertible loan to Solterra |  |  | - |  |  |  | - |  |  |  | 346 |  |  |  | 346 |
Total assets |  |  | 1,012 |  |  |  | - |  |  |  | 2,075 |  |  |  | 3,087 |
|  | Level 1 |  |  | Level 2 |  |  | Level 3 |  |  | Total |
|  | As of December 31, 2024 |
|  | Level 1 |  |  | Level 2 |  |  | Level 3 |  |  | Total |
|  | US$ |
Assets: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Investment in Plantify |  |  | 603 |  |  |  | - |  |  |  | - |  |  |  | 603 |
Investment in Solterra |  |  | 307 |  |  |  | - |  |  |  | - |  |  |  | 307 |
Solar photovoltaic joint venture project |  |  | - |  |  |  | - |  |  |  | 808 |  |  |  | 808 |
Loan granted to MitoCareX |  |  | - |  |  |  | - |  |  |  | 234 |  |  |  | 234 |
Convertible loan to Solterra |  |  | - |  |  |  | - |  |  |  | 350 |  |  |  | 350 |
Total assets |  |  | 910 |  |  |  | - |  |  |  | 1,392 |  |  |  | 2,302 |
The Company’s financial liabilities that are measured at fair value on a recurring basis by level within the fair value hierarchy are as follows:
|  | Level 1 |  |  | Level 2 |  |  | Level 3 |  |  | Total |
|  | As of March 31, 2025 |
|  | Level 1 |  |  | Level 2 |  |  | Level 3 |  |  | Total |
|  | US$ |
Liabilities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stock purchase warrants liability |  |  | - |  |  |  | - |  |  |  | 1,912 |  |  |  | 1,912 |
warrant liabilities to Pure Capital |  |  | - |  |  |  | - |  |  |  | 415 |  |  |  | 415 |
Credit facility |  |  | - |  |  |  | - |  |  |  | 764 |  |  |  | 764 |
Total liabilities |  |  | - |  |  |  | - |  |  |  | 3,091 |  |  |  | 3,091 |
|  | Level 1 |  |  | Level 2 |  |  | Level 3 |  |  | Total |
|  | As of December 31, 2024 |
|  | Level 1 |  |  | Level 2 |  |  | Level 3 |  |  | Total |
|  | US$ |
Liabilities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
warrant liabilities to Pure Capital |  |  | - |  |  |  | - |  |  |  | 312 |  |  |  | 312 |
Total liabilities |  |  | - |  |  |  | - |  |  |  | 312 |  |  |  | 312 |
SCHEDULE OF FAIR VALUE OF THE LEVELS 3 ASSETS | The following table presents the changes in fair value of the level 3 assets for the period December 31, 2024 through March 31, 2025: SCHEDULE OF FAIR VALUE OF THE LEVELS 3 ASSETS
|  | Solar photovoltaic joint venture project |  |  | Loan granted to MitoCareX |  |  | Convertible loan to Solterra |  |  | Total |
|  | US$ |
Assets: |  |  |  |  |  |  |  |  |  |  |  |
Outstanding at December 31, 2024 |  |  | 808 |  |  |  | 234 |  |  |  | 350 |  |  |  | 1,392 |
Additions during the period |  |  | 362 |  |  |  | 250 |  |  |  | - |  |  |  | 612 |
Changes in fair value |  |  | 82 |  |  |  | (7 | ) |  |  | (4 | ) |  |  | 71 |
Outstanding at March 31, 2025 |  |  | 1,252 |  |  |  | 477 |  |  |  | 346 |  |  |  | 2,075 |

X
- References No definition available. + Details
Name: | NITO_DisclosureCreditFacilityAbstract
Namespace Prefix: | NITO_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3). + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 + Details
Name: | us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of financial instrument classified as a derivative asset (liability) after deduction of derivative liability (asset) using recurring unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 + Details
Name: | us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration